| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18580626 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 102 journal articles in the PubMed database | Email to a friend | | |
| Bani-Sadr F, Goderel I, Lapidus N, et al.
Risk factors for bacterial infections in HIV/hepatitis C virus-coinfected patients treated with interferon plus ribavirin. [Letter, Research Support, Non-U.S. Gov't]
AIDS 2008 Jul 11; 22(11):1385-7.
Full Citation | Publisher Full Text | Find Related Articles | | Chung RT, Andersen J, Volberding P, et al.
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2004 Jul 29; 351(5):451-9.
Abstract | Full Citation | Find Related Articles | | Crespo M, Sauleda S, Esteban JI, et al.
Peginterferon alpha-2b plus ribavirin vs interferon alpha-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients. [Journal Article, Research Support, Non-U.S. Gov't]
J Viral Hepat 2007 Apr; 14(4):228-38.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Callens S, Bottieau E, Michielsen P, et al.
Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. [Case Reports, Comment, Letter]
AIDS 2004 Jan 2; 18(1):131.
Full Citation | Publisher Full Text | Find Related Articles | | Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al.
Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
N Engl J Med 2004 Jul 29; 351(5):438-50.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Bani-Sadr F, Goderel I, Penalba C, et al.
Risk factors for anaemia in human immunodeficiency virus/hepatitis C virus-coinfected patients treated with interferon plus ribavirin. [JOURNAL ARTICLE]
J Viral Hepat 2007 Sep; 14(9):639-644.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Mira JA, López-Cortés LF, Merino D, et al.
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. [Journal Article, Research Support, Non-U.S. Gov't]
Antivir Ther 2007; 12(8):1225-35.
Abstract | Full Citation | | Manjón-Haces JA, Vázquez-López F, Gómez-Díez S, et al.
Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. [Letter]
Acta Derm Venereol 2001 Jun-Jul; 81(3):223.
Full Citation | Find Related Articles | | Bani-Sadr F, Carrat F, Rosenthal E, et al.
Spontaneous hepatic decompensation in patients coinfected with HIV and hepatitis C virus during interferon-ribavirin combination treatment. [Journal Article]
Clin Infect Dis 2005 Dec 15; 41(12):1806-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
New! 